CVI Holdings’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

CVI Holdings’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-49,738	Closed	-$10K	–	679
2022 Q3	$10K	Sell	49,738 -17,596	-26%	-$2.75K	﹤0.01%	627
2022 Q2	$13K	Sell	67,334 -942	-1%	-$255	﹤0.01%	691
2022 Q1	$24K	Sell	68,276 -20,186	-23%	-$10.3K	﹤0.01%	747
2021 Q4	$78K	Hold	88,462	–	–	0.01%	685
2021 Q3	$144K	Buy	88,462 +21,796	+33%	+$26.4K	0.01%	567
2021 Q2	$67K	Hold	66,666	–	–	﹤0.01%	666
2021 Q1	$41K	Buy	+66,666	New	+$64.3K	﹤0.01%	566

Other funds holding EFTRW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

ECM

Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

ICM

III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

CVI Holdings's EFTRW Position: Q4 2022 in Review

CVI Holdings sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q4 2022, closing a stake of 49,738 shares — an estimated $10K sold.

CVI Holdings first reported a position in EFTRW in Q1 2021 and held it in 7 quarters. The position peaked at $144K in Q3 2021. 12 funds tracked by Wall St. Rank hold EFTRW as of Q4 2022.

CVI Holdings reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 49,738 eFFECTOR Therapeutics, Inc. Warrant shares in Q4 2022, an estimated $10K.
CVI Holdings first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2021 and held it in 7 quarters.
CVI Holdings's eFFECTOR Therapeutics, Inc. Warrant position peaked at $144K in Q3 2021.
12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.